SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007747
Filing Date
2019-08-08
Accepted
2019-08-08 17:02:01
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20190630x10q.htm   iXBRL 10-Q 2056689
2 EX-10.1 icpt-20190630ex101b605bb.htm EX-10.1 158707
3 EX-10.2 icpt-20190630ex102c9d31d.htm EX-10.2 141823
4 EX-31.1 icpt-20190630ex3110d87a3.htm EX-31.1 12876
5 EX-31.2 icpt-20190630ex31296dd82.htm EX-31.2 12589
6 EX-32.1 icpt-20190630ex321407796.htm EX-32.1 14585
  Complete submission text file 0001558370-19-007747.txt   7712835

Data Files

Seq Description Document Type Size
7 EX-101.SCH icpt-20190630.xsd EX-101.SCH 44506
8 EX-101.CAL icpt-20190630_cal.xml EX-101.CAL 61591
9 EX-101.DEF icpt-20190630_def.xml EX-101.DEF 137826
10 EX-101.LAB icpt-20190630_lab.xml EX-101.LAB 368773
11 EX-101.PRE icpt-20190630_pre.xml EX-101.PRE 316781
12 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20190630x10q_htm.xml XML 1381062
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 191010435
SIC: 2834 Pharmaceutical Preparations